Java 25, an LTS (long-term support) version, is now at release candidate (RC) stage with general availability scheduled for September 16. The RC release is the first of two, with the second set for ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

CHAPEL HILL, N.C. — You have cancer. That’s the devastating news the National Cancer Institute says some 2 million people in the United States will receive this year. It’s a difficult diagnosis to ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

Jakarta EE, a working group hosted by the Eclipse Foundation, today announced the general availability of the Jakarta EE 11 Platform, the latest version of its enterprise Java platform. The new ...

HOUSTON, Texas (KTRK) -- Harris County leaders waved the white flag on a program that would've given families a guaranteed income. Uplife Harris ends before it begins More than a year ago, Harris ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...

REDMOND, Wash. — May 6, 2025 — Microsoft Corp. and the National FFA Organization on Tuesday announced the national expansion of FarmBeats for Students, a cutting-edge educational program integrating ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

Stephen Dowd had been living homeless in Seattle for more than a year and a half, using fentanyl, when he was swept up in an Uber near Dick’s Drive-In in Uptown and driven to a treatment center in ...

SAN FRANCISCO--(BUSINESS WIRE)-- Vir Biotechnology, Inc. (VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is ...